Results 231 to 240 of about 52,122 (312)

Butorphanol Pharmacokinetics Across Species: Meta‐Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic Modeling

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 7, July 2026.
mPBPK Allometric Meta‐Analysis (MAMA) of Butorphanol Across 13 Species. ABSTRACT Butorphanol, an opioid agonist–antagonist used in human and veterinary medicine, lacks systematic interspecies comparisons. Butorphanol pharmacokinetics (PK) was assessed across species using a minimal physiologically based PK (mPBPK) model and allometric scaling, termed ...
Ahmed M. Saeed, William J. Jusko
wiley   +1 more source

The potential use of digital technologies to enhance opioid agonist treatment in rural and remote communities of British Columbia, Canada. [PDF]

Harm Reduct J
Jayathilake A, Hodgson K, Mansoor M, Markel K, Bardwell G.   +4 more
europepmc   +1 more source

Effect of Intranasal Midazolam–Butorphanol Premedication on Sevoflurane Anaesthesia in Traumatised Buzzards (Buteo spp.)

Veterinary Medicine and Science, Volume 12, Issue 4, July 2026.
Intranasal midazolam–butorphanol premedication in traumatised buzzards (Buteo spp.) aims to provide safer sedation by minimising mask induction stress. This method significantly reduces sevoflurane requirements while maintaining stable cardiopulmonary parameters. It is a safe and practical alternative that enhances patient welfare and induction quality.
Can Nacar, Hatice Ozlem Nisbet
wiley   +1 more source

Low Testosterone Among Males in Opioid Agonist Therapy and Its Association With Fatigue and Psychological Distress. [PDF]

J Endocr Soc
Vold JH, Vogt EC, Heldal AT, Chalabianloo F, Druckrey-Fiskaaen KT, Løberg EM, Methlie P, Johansson KA, Fadnes LT.   +8 more
europepmc   +1 more source

A Multispecies Systematic and Critical Review of Intranasal Administration in Veterinary Anaesthesia and Emergency Care: Promising Evidence and Overlooked Challenges

Veterinary Medicine and Science, Volume 12, Issue 4, July 2026.
This review evaluates the clinical potential and limitations of intranasal (IN) drug administration in veterinary anaesthesia and emergency care. IN delivery can provide clinically relevant sedation, analgesia and drug reversal, but its success is not universally reliable and is strongly influenced by species‐specific anatomy, formulation ...
Majid Jafarbeglou
wiley   +1 more source

Harnessing telemedicine to deliver patient-centered opioid agonist treatment within a community-based harm reduction service: a mixed methods evaluation. [PDF]

Harm Reduct J
Høj SB, Coignard-Friedman R, Sako A, de Montigny C, Beauchemin-Nadeau MÈ, Léandre R, Minoyan N, Boyer-Legault G, Chougar S, Lamont SK, Bruneau J.   +10 more
europepmc   +1 more source

Prenatal Prescription Opioid Analgesic Exposure and Academic Performance in Third Grade Children: A Population‐Based Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 8, Page 1658-1670, July 2026.
ABSTRACT Objective To evaluate the association between prenatal exposure to opioids analgesics and academic performance in third grade children. Design Population‐based cohort study using linked data from New South Wales birth records, medicine dispensing data, and national standardised test results.
Bianca Varney, Helga Zoega, Malcolm B. Gillies, Claudia Bruno, Alys Havard, Antonia Shand, Natasha Nassar, Jonathan Brett   +7 more
wiley   +1 more source

Disparities in Opioid Agonist Treatment Accessibility for Priority Populations in New South Wales, Australia. [PDF]

Drug Alcohol Rev
Conigrave JH, Dobbins T, Buckley NA, Lee KSK, Morley KC, Doyle M, Al-Ansari B, Wilson S, Loggins S, Conigrave K.   +9 more
europepmc   +1 more source

Initiation of High‐Potency Benzodiazepine Prescriptions Among Survivors of Severe Trauma

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.
ABSTRACT Background Trauma is a major public health concern that often leads to long‐term psychological distress and chronic pain. Benzodiazepines (BZDs) are sometimes prescribed for anxiety, insomnia, or acute stress‐related symptoms, but long‐term use is associated with dependence and adverse outcomes.
Anders Oldner, Mikael Eriksson, Emma Larsson, Jesper Eriksson, Erik von Oelreich   +4 more
wiley   +1 more source

Retention in Opioid Agonist Therapy Among First Nations People.

JAMA Netw Open
Holton A, Hamzat B, McCormack D, Bragg S, deGonzague B, Mecredy G, Campbell T, Antoniou T, McGregor L, Bertram J, Gomes T.   +10 more
europepmc   +1 more source